Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Yamanouchi Pharma Technologies Inc.

Division of Astellas Pharma Inc.

Latest From Yamanouchi Pharma Technologies Inc.

Deals of the Week: Options Abound As Forest Keeps Its Eyes On A Prize-Winner

Reflecting a long trend, three of this past week’s deals include option arrangements, including one with a new twist. Also, a rare disease partnership between Shire and Atlas Venture finally leads to a deal and Takeda continues building its vaccines business.

BioPharmaceutical Deals

Drais In Third Deal With Astellas, Seeks To Expand Partnership Model

Astellas has returned for a third time to enlist the development services of Drais, out-licensing a nocturia candidate which Drais will house in a virtual development company, Tacurion. Drais’ challenge now is to expand its portfolio of single-asset companies and its roster of investors.

Deals Strategy

Yamanouchi's Foray Into Drug Delivery

Yamanouchi attempts to use its drug delivery business (Yamanouchi Shaklee Pharma) to help jumpstart its efforts to gain a foothold in the US and to eventually become a true global player. Yamanouchi's support of YSP may, however, be a two-edged sword: it provides YSP with the kind of financial support that most drug delivery companies can only dream of, but it may also scare off potential partners.
BioPharmaceutical North America
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
  • Therapeutic Areas
  • Alias(es)
  • Yamanouchi Shaklee Pharma
  • Ownership
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Astellas Pharma Inc.
  • Senior Management
  • Dan Green, Pres. & COO
    Joseph Fix, PhD, SVP & CTO
  • Contact Info
  • Yamanouchi Pharma Technologies Inc.
    Phone: (650) 849-8595
    1050 Arastradero Rd.
    Palo Alto, CA 94304
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register